273 related articles for article (PubMed ID: 19074089)
1. Thrombophilia states and markers of coagulation activation in the prediction of pediatric venous thromboembolic outcomes: a comparative analysis with respect to adult evidence.
Goldenberg NA
Hematology Am Soc Hematol Educ Program; 2008; ():236-44. PubMed ID: 19074089
[TBL] [Abstract][Full Text] [Related]
2. Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: A systematic review and meta-analysis.
Zia A; Russell J; Sarode R; Veeram SR; Josephs S; Malone K; Zhang S; Journeycake J
Thromb Res; 2017 Dec; 160():1-8. PubMed ID: 29078111
[TBL] [Abstract][Full Text] [Related]
3. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
4. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
5. Uncertain thrombophilia markers.
Franchini M; Martinelli I; Mannucci PM
Thromb Haemost; 2016 Jan; 115(1):25-30. PubMed ID: 26271270
[TBL] [Abstract][Full Text] [Related]
6. In Children with Provoked Venous Thromboembolism, Increasing Plasma Coagulability during the First 3 Months Postdiagnosis is Prognostic of Recurrence.
Betensky M; Mueller MG; Amankwah EK; Goldenberg NA
Thromb Haemost; 2020 May; 120(5):823-831. PubMed ID: 32369853
[TBL] [Abstract][Full Text] [Related]
7. Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia.
Wichers IM; Tanck MW; Meijers JC; Lisman T; Reitsma PH; Rosendaal FR; Büller HR; Middeldorp S
Thromb Haemost; 2009 Mar; 101(3):465-70. PubMed ID: 19277406
[TBL] [Abstract][Full Text] [Related]
8. Predicting the risk of recurrent venous thromboembolism. The Austrian study on recurrent venous thromboembolism (AUREC).
Kyrle PA; Eischer L
Hamostaseologie; 2013 Aug; 33(3):201-9. PubMed ID: 23712242
[TBL] [Abstract][Full Text] [Related]
9. Thrombophilia and hypercoagulability.
Hassouna HI
Med Princ Pract; 2009; 18(6):429-40. PubMed ID: 19797918
[TBL] [Abstract][Full Text] [Related]
10. Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation.
Weingarz L; Schindewolf M; Schwonberg J; Hecking C; Wolf Z; Erbe M; Lindhoff-Last E; Linnemann B
Vasa; 2015 Jul; 44(4):313-23. PubMed ID: 26314364
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
12. Thrombophilia and venous thromboembolism: implications for testing.
Cohn DM; Roshani S; Middeldorp S
Semin Thromb Hemost; 2007 Sep; 33(6):573-81. PubMed ID: 17768689
[TBL] [Abstract][Full Text] [Related]
13. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
[TBL] [Abstract][Full Text] [Related]
14. Pathology consultation on the laboratory evaluation of thrombophilia: when, how, and why.
Ballard RB; Marques MB;
Am J Clin Pathol; 2012 Apr; 137(4):553-60. PubMed ID: 22431530
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20years?
Kenet G; Limperger V; Shneyder M; Nowak-Göttl U
Blood Cells Mol Dis; 2017 Sep; 67():18-22. PubMed ID: 28010922
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
17. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism in neonates and children.
Kenet G; Nowak-Göttl U
Best Pract Res Clin Haematol; 2012 Sep; 25(3):333-44. PubMed ID: 22959549
[TBL] [Abstract][Full Text] [Related]
19. Classic thrombophilic gene variants.
Mannucci PM; Franchini M
Thromb Haemost; 2015 Nov; 114(5):885-9. PubMed ID: 26018405
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: a prospective study.
Korkeila P; Mustonen P; Koistinen J; Nyman K; Ylitalo A; Karjalainen P; Lund J; Airaksinen J
Europace; 2010 Jun; 12(6):817-24. PubMed ID: 20348141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
